Desmoglein 1 (DSG1) and Desmoglein 3 (DSG3), IgG Antibody
Desmogleins are cadherin-type adhesion proteins that are integral components of desmosomes, which provide structural integrity to epithelial tissues including skin, mucous membranes, and myocardium. Among the four desmogleins, DSG1 is predominantly expressed in the upper layers of the epidermis, whereas DSG3 is expressed in the basal and suprabasal layers of the epidermis and mucosal epithelium. Autoantibodies directed against desmogleins cause pemphigus, a group of acquired autoimmune blistering diseases.
- Pemphigus foliaceus: Associated with IgG autoantibodies targeting DSG1; presents with superficial blisters and erosions, usually without mucosal involvement.
- Pemphigus vulgaris: Associated with IgG autoantibodies targeting DSG3 (and sometimes DSG1); presents with flaccid blisters and painful erosions involving both skin and mucous membranes. Pemphigus vulgaris accounts for ~80% of pemphigus cases.
Detection of IgG antibodies to DSG1 and DSG3 is valuable for confirming diagnosis, distinguishing between pemphigus subtypes, and monitoring disease activity.
- As an aid in the diagnosis and differentiation of pemphigus vulgaris and pemphigus foliaceus
- Supports evaluation of patients with blistering diseases affecting skin and/or mucous membranes
Positive DSG1 antibodies: Supports diagnosis of pemphigus foliaceus.
Positive DSG3 antibodies: Supports diagnosis of pemphigus vulgaris.
Both DSG1 and DSG3 positive: Often observed in mucocutaneous pemphigus vulgaris.
Negative results do not rule out pemphigus; correlation with clinical and histopathologic findings is essential.
Desmoglein 1: <20 RU/mL (Negative) and >=20 RU/mL (Positive) Desmoglein 3: <20 RU/mL (Negative) and >=20 RU/mL (Positive)
Serum, SST tube.
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: 30 days
- J Chin Med Assoc. 2007 Feb;70(2):65-70. [PMID: 17339147]
- Br J Dermatol. 1999 Feb;140(2):351-7. [PMID: 10233237]
- Arch Dermatol. 1999 Aug;135(8):943-7. [PMID: 10456343]
- Medicina (Kaunas). 2021 Oct 9;57(10):1080. [PMID: 34684117]
- Front Immunol. 2019 May 24;10:1128. [PMID: 31178865]